This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Evaluating the potential of VNDA's Tradipitant in treating Gastroparesis prior to P3 Readout

Ticker(s): VNDA

Who's the expert?

Institution: Harvard & Beth Israel Deaconess Medical Center

  • Assistant Professor of Medicine at Harvard Medical School, Gastroenterologist at BIDMC & Director of Community Endoscopy for BIDMC.
  • Manages over 100 patients with gastroparesis.
  • Special areas of interest include: enteral and parenteral nutrition, intestinal failure, and gastrointestinal dysmotility;has developed national and international reputation based on his expertise in nutrition support, intestinal failure, gastric dysmotility and bariatric surgery complications.   

Interview Goal
This conversation will focus on the potential of Tradipitant and will discuss the Phase 2 study results for Tradipitant in treating Gastroparesis published in the Journal of Gastroenterology in January 2021.

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.